Guardian Pharmacy Services Stock Performance
| GRDN Stock | 33.43 0.03 0.09% |
On a scale of 0 to 100, Guardian Pharmacy holds a performance score of 9. The company retains a Market Volatility (i.e., Beta) of 1.49, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Guardian Pharmacy will likely underperform. Please check Guardian Pharmacy's coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Guardian Pharmacy's current trending patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Guardian Pharmacy Services are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Guardian Pharmacy displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.94 | Five Day Return (0.68) | Year To Date Return 13.31 | Ten Year Return 109.13 | All Time Return 109.13 |
1 | Disposition of 21500 shares by Forbes Kendall of Guardian Pharmacy subject to Rule 16b-3 | 12/04/2025 |
2 | Guardian Pharmacy Services, Inc. to Participate in Upcoming J.P. Morgan Healthcare Conference | 12/15/2025 |
3 | Guardian Pharmacy Services Trading Down 0.8 percent - Should You Sell - MarketBeat | 12/31/2025 |
4 | Implied Volatility Surging for Guardian Pharmacy Services Stock Options | 01/07/2026 |
5 | Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook | 01/13/2026 |
6 | Guardian Pharmacy Services Trading Down 6.9 percent Heres What Happened | 01/16/2026 |
7 | Stephens Is Bullish on Guardian Pharmacy Services, Inc. After 2026 Forecast Update | 01/26/2026 |
8 | Guardian Pharmacy Services Inc A Fair Value For Market Watchers | 02/02/2026 |
9 | Guardian Pharmacy Services, Inc Stock Analysis Reveals 2.67 percent Potential Upside Amid Robust Revenue Growth - DirectorsTalk Interviews | 02/10/2026 |
10 | Acquisition by David Morris of 50000 shares of Guardian Pharmacy at 34.59 subject to Rule 16b-3 | 02/11/2026 |
11 | New York State Common Retirement Fund Sells 347,524 Shares of Guardian Pharmacy Services, Inc. GRDN - MarketBeat | 02/13/2026 |
| Begin Period Cash Flow | 752 K | |
| Total Cashflows From Investing Activities | -30.4 M |
Guardian Pharmacy Relative Risk vs. Return Landscape
If you would invest 2,791 in Guardian Pharmacy Services on November 18, 2025 and sell it today you would earn a total of 552.00 from holding Guardian Pharmacy Services or generate 19.78% return on investment over 90 days. Guardian Pharmacy Services is currently generating 0.3242% in daily expected returns and assumes 2.5786% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than Guardian, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Guardian Pharmacy Target Price Odds to finish over Current Price
The tendency of Guardian Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 33.43 | 90 days | 33.43 | under 4 |
Based on a normal probability distribution, the odds of Guardian Pharmacy to move above the current price in 90 days from now is under 4 (This Guardian Pharmacy Services probability density function shows the probability of Guardian Stock to fall within a particular range of prices over 90 days) .
Guardian Pharmacy Price Density |
| Price |
Predictive Modules for Guardian Pharmacy
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Guardian Pharmacy. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardian Pharmacy's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Guardian Pharmacy Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Guardian Pharmacy is not an exception. The market had few large corrections towards the Guardian Pharmacy's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Guardian Pharmacy Services, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Guardian Pharmacy within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.12 | |
β | Beta against Dow Jones | 1.49 | |
σ | Overall volatility | 1.59 | |
Ir | Information ratio | 0.05 |
Guardian Pharmacy Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Guardian Pharmacy for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Guardian Pharmacy can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 1.23 B. Net Loss for the year was (71.03 M) with profit before overhead, payroll, taxes, and interest of 274.32 M. | |
| Guardian Pharmacy has a poor financial position based on the latest SEC disclosures | |
| About 59.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: New York State Common Retirement Fund Sells 347,524 Shares of Guardian Pharmacy Services, Inc. GRDN - MarketBeat |
Guardian Pharmacy Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Guardian Stock often depends not only on the future outlook of the current and potential Guardian Pharmacy's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Guardian Pharmacy's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 62 M | |
| Cash And Short Term Investments | 4.7 M |
Guardian Pharmacy Fundamentals Growth
Guardian Stock prices reflect investors' perceptions of the future prospects and financial health of Guardian Pharmacy, and Guardian Pharmacy fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Guardian Stock performance.
| Return On Equity | 0.24 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 2.12 B | ||||
| Shares Outstanding | 36.25 M | ||||
| Price To Book | 11.53 X | ||||
| Price To Sales | 1.52 X | ||||
| Revenue | 1.23 B | ||||
| Gross Profit | 274.32 M | ||||
| EBITDA | (43.43 M) | ||||
| Net Income | (71.03 M) | ||||
| Total Debt | 37.33 M | ||||
| Book Value Per Share | 2.90 X | ||||
| Cash Flow From Operations | 57.96 M | ||||
| Earnings Per Share | 0.68 X | ||||
| Market Capitalization | 2.12 B | ||||
| Total Asset | 320.81 M | ||||
| Retained Earnings | 17.12 M | ||||
| Working Capital | 7.86 M | ||||
About Guardian Pharmacy Performance
By examining Guardian Pharmacy's fundamental ratios, stakeholders can obtain critical insights into Guardian Pharmacy's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Guardian Pharmacy is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 17.30 | 20.79 | |
| Return On Tangible Assets | (0.42) | (0.40) | |
| Return On Capital Employed | (0.41) | (0.39) | |
| Return On Assets | (0.31) | (0.30) | |
| Return On Equity | (0.70) | (0.67) |
Things to note about Guardian Pharmacy performance evaluation
Checking the ongoing alerts about Guardian Pharmacy for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Guardian Pharmacy help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 1.23 B. Net Loss for the year was (71.03 M) with profit before overhead, payroll, taxes, and interest of 274.32 M. | |
| Guardian Pharmacy has a poor financial position based on the latest SEC disclosures | |
| About 59.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: New York State Common Retirement Fund Sells 347,524 Shares of Guardian Pharmacy Services, Inc. GRDN - MarketBeat |
- Analyzing Guardian Pharmacy's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Guardian Pharmacy's stock is overvalued or undervalued compared to its peers.
- Examining Guardian Pharmacy's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Guardian Pharmacy's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Guardian Pharmacy's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Guardian Pharmacy's stock. These opinions can provide insight into Guardian Pharmacy's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardian Pharmacy Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Will Consumer Staples Distribution & Retail sector continue expanding? Could Guardian diversify its offerings? Factors like these will boost the valuation of Guardian Pharmacy. Market participants price Guardian higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Guardian Pharmacy data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 0.2 | Return On Assets | Return On Equity |
Understanding Guardian Pharmacy requires distinguishing between market price and book value, where the latter reflects Guardian's accounting equity. The concept of intrinsic value - what Guardian Pharmacy's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Guardian Pharmacy's price substantially above or below its fundamental value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Guardian Pharmacy's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.